-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected
-
-
-
-
-
-
-
Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
-
-
-
-
-
-
-
Lilly's Jaypirca reduces disease progression risk by 45% in CLL study
-
-
-
-
-
-
-
Eli Lilly reports positive results for obesity drug retatrutide trials
-
-
-
-
-
-
-
Camurus (CAMX) announces expansion of Lilly collaboration, decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal technology
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,251 at BofA Securities
-
-
-
-
-
-
-
Trump to unveil more discounted prescription drug options - CNBC
-
427,846 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

